GPT and ganglioneuroma: Serum ALT levels were elevated 2- and 4-fold after dosing with 30 mg/kg HsPCSK9-1811-LNA or 3 mg/kg HsPCSK9-1811-LNA-GN, respectively, compared to the level in the saline-treated control (Figure 5A).